The agency approved Novartis' Rydapt for AML patients with FLT3 mutations, who will be identified by Invivoscribe's LeukoStrat CDx.
Parental smoking linked to deletions observed among children with acute lymphoblastic leukemia, CBS News reports.
The test runs on Qiagen's Rotor-Gene Q MDx system and is designed to qualitatively detect the JAK2 V617F/G1849T allele in genomic DNA from whole blood.
In Cell this week: TIRAP mutation effect reversed, ultraviolet exposure effects on transcription, and more.
MLL will be the first European user of Illumina's new high-throughput sequencing platform, the NovaSeq.
VISION aims to provide validated regulatory modules, quantitative models for gene regulation, and guides for translating research from mouse models to human.
In Cell this week: essential genes in AML, indel hotspots affect certain genes in cancer, and more.
In Science this week: tomato sequencing identifies flavor compounds lost in modern varieties, and more.
Two children treated with a gene-editing therapy for their leukemia are healthy a year later, according to New Scientist.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.